BRAI 2013 - 8th Brain Research Conference: RNA Metabolism in Neurological Disease

Website http://www.brainresearchconference.com | Edit Freely

Category ALS/FTD: TDP-43; FUS, C9ORF72; Myotonic dystrophy; FXTAS; SMA; Any connections to AD; MicroRNAs and other ncRNAs; Therapeutics: ASOs, siRNA

Deadline: May 31, 2013 | Date: November 07, 2013-November 08, 2013

Venue/Country: San Diego, U.S.A

Updated: 2013-01-17 01:23:37 (GMT+9)

Call For Papers - CFP

7-8 November 2013, San Diego, USA

Official Satellite to the 2013 Meeting of the Society for Neuroscience

Complex networks of RNA-protein interactions regulate post-transcriptional gene expression. RNA metabolism is particularly complex in neurons, involving extensive diversification of gene expression through splicing and redistribution of RNA subsets to the distant compartments where they ultimately function. In recent years, perturbation of RNA metabolism has emerged as a consistent underlying defect in certain neurological diseases, suggesting that aspects of RNA metabolism that are unique to the nervous system may also create unique vulnerabilities.

This two day symposium organized by Paul Taylor and Fen-Biao Gao will bring together basic and clinical scientists to discuss the role of perturbed RNA metabolism in neurological diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), spinal muscular atrophy (SMA), repeat expansion disorders, and others.

Topics List

Abstracts are invited for poster presentation at the conference on the following suggested topics:

? ALS/FTD: TDP-43, FUS, C9ORF72

? Myotonic dystrophy

? FXTAS

? SMA

? Any connections to AD

? MicroRNAs and other ncRNAs

? Therapeutics: ASOs, siRNA

Conference Chairs

Fen-Biao Gao, University of Massachusetts Medical School, MA, USA

J. Paul Taylor, St. Jude Children's Research Hospital, Memphis, USA

Keynote Speaker

Philip Sharp, Massachusetts Institute of Technology, USA

For more information, visit: http://www.brainresearchconference.com

Keywords:

? RNA Metabolism

? Neurological Disease

? ALS/FTD: TDP-43, FUS, C9ORF72

? Myotonic dystrophy

? FXTAS

? SMA

? Any connections to AD

? MicroRNAs and other ncRNAs

? Therapeutics: ASOs, siRNA